Some results of perinatal complications in pregnant women with polycystic ovary syndrome

Abstract

Purpose. Evaluation of the results of complications in the perinatal period in pregnant women with (PCOS) polycystic ovary syndrome. Material and methods. The research carried out for the accumulation, processing and analysis of data was a retrospective study that was carried out during the years 2020-2022 within IMSP SCM no. 1, the patients were divided into 2 groups: Group I – 60 patients with polycystic ovary syndrome and pregnancy achieved. Group II – 60 patients with normal pregnancy. According to its character, the study carried out is descriptive observational. The method of accumulating and extracting data from the medical documentation did not allow the determination of anamnestic-clinical peculiarities, clinical and paraclinical investigations (laboratory and instrumental), the evolution of the pregnancy and the birth of the pregnant women included in the study, including the assessment of the status of the newborn at birth. Results. From the results of the study, it can be confirmed that there were no statistically significant differences (>0.05) between the 2 groups included in the study. Live children were born - 50 (94.34±0.32) in group I compared to 58 (96.7±0.63) in group II. Neonatal death was registered only in group I – 3 (5.66±0.32) cases and neonatal death only in group II – 2 (3.3±0.63) cases. Conclusion. The results of the comparative study show that pregnancy in pregnant women with PCOS ends with macrosomicfetuses - 26.43%; with an Apgar score of 7-8 in – 38.3%; who did not require transfer to the neonatal intensive care unit – 64%. Strict antenatal monitoring of pregnancy remains the gold standard for favorable perinatal outcomes.